Literature DB >> 16610002

Up-regulation of NAD(P)H quinone oxidoreductase 1 during human liver injury.

Lauren M Aleksunes1, Michael Goedken, José E Manautou.   

Abstract

AIM: To investigate the expression and activity of NAD(P)H quinone oxidoreductase 1 (NQO1) in human liver specimens obtained from patients with liver damage due to acetaminophen (APAP) overdose or primary biliary cirrhosis (PBC).
METHODS: NQO1 activity was determined in cytosol from normal, APAP and PBC liver specimens. Western blot and immunohistochemical staining were used to determine patterns of NQO1 expression using a specific antibody against NQO1.
RESULTS: NQO1 protein was very low in normal human livers. In both APAP and PBC livers, there was strong induction of NQO1 protein levels on Western blot. Correspondingly, significant up-regulation of enzyme activity (16- and 22-fold, P< 0.05) was also observed in APAP and PBC livers, respectively. Immunohistochemical analysis highlighted injury-specific patterns of NQO1 staining in both APAP and PBC livers.
CONCLUSION: These data demonstrate that NQO1 protein and activity are markedly induced in human livers during both APAP overdose and PBC. Up-regulation of this cytoprotective enzyme may represent an adaptive stress response to limit further disease progression by detoxifying reactive species.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16610002      PMCID: PMC4087521          DOI: 10.3748/wjg.v12.i12.1937

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  20 in total

1.  Differential gene expression of NAD(P)H:quinone oxidoreductase and NRH:quinone oxidoreductase in human hepatocellular and biliary tissue.

Authors:  Ahlke Strassburg; Christian P Strassburg; Michael P Manns; Robert H Tukey
Journal:  Mol Pharmacol       Date:  2002-02       Impact factor: 4.436

Review 2.  NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms.

Authors:  D Ross; J K Kepa; S L Winski; H D Beall; A Anwar; D Siegel
Journal:  Chem Biol Interact       Date:  2000-12-01       Impact factor: 5.192

3.  Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice.

Authors:  M Ramos-Gomez; M K Kwak; P M Dolan; K Itoh; M Yamamoto; P Talalay; T W Kensler
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

4.  Disruption of the DT diaphorase (NQO1) gene in mice leads to increased menadione toxicity.

Authors:  V Radjendirane; P Joseph; Y H Lee; S Kimura; A J Klein-Szanto; F J Gonzalez; A K Jaiswal
Journal:  J Biol Chem       Date:  1998-03-27       Impact factor: 5.157

Review 5.  Quinone reductases multitasking in the metabolic world.

Authors:  David Ross
Journal:  Drug Metab Rev       Date:  2004-10       Impact factor: 4.518

6.  NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger.

Authors:  David Siegel; Daniel L Gustafson; Donna L Dehn; Jin Yi Han; Preecha Boonchoong; Lawrence J Berliner; David Ross
Journal:  Mol Pharmacol       Date:  2004-05       Impact factor: 4.436

7.  Bromobenzene-induced hepatotoxicity at the transcriptome level.

Authors:  Wilbert H M Heijne; Angela L Slitt; Peter J van Bladeren; John P Groten; Curtis D Klaassen; Rob H Stierum; Ben van Ommen
Journal:  Toxicol Sci       Date:  2004-03-31       Impact factor: 4.849

8.  Molecular signature in three types of hepatocellular carcinoma with different viral origin by oligonucleotide microarray.

Authors:  Norio Iizuka; Masaaki Oka; Hisafumi Yamada-Okabe; Kenji Hamada; Hironobu Nakayama; Naohide Mori; Takao Tamesa; Toshimasa Okada; Norikazu Takemoto; Katsuhiro Matoba; Motonari Takashima; Katsuhiko Sakamoto; Akira Tangoku; Takanobu Miyamoto; Shunji Uchimura; Yoshihiko Hamamoto
Journal:  Int J Oncol       Date:  2004-03       Impact factor: 5.650

9.  Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence.

Authors:  Paul Nioi; Michael McMahon; Ken Itoh; Masayuki Yamamoto; John D Hayes
Journal:  Biochem J       Date:  2003-09-01       Impact factor: 3.857

Review 10.  Acute liver failure in the United States.

Authors:  William M Lee
Journal:  Semin Liver Dis       Date:  2003-08       Impact factor: 6.115

View more
  27 in total

1.  Diethylnitrosamine-induced cirrhosis in Wistar rats: an experimental feasibility study.

Authors:  Silvia Bona; Andrea Janz Moreira; Graziella Ramos Rodrigues; Carlos Thadeu Cerski; Themis Reverbel da Silveira; Claudio Augusto Marroni; Norma Possa Marroni
Journal:  Protoplasma       Date:  2014-11-05       Impact factor: 3.356

2.  Nrf2-mediated liver protection by sauchinone, an antioxidant lignan, from acetaminophen toxicity through the PKCδ-GSK3β pathway.

Authors:  Hee Yeon Kay; Young Woo Kim; Da Hye Ryu; Sang Hyun Sung; Se Jin Hwang; Sang Geon Kim
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

3.  CDDO-Im protects from acetaminophen hepatotoxicity through induction of Nrf2-dependent genes.

Authors:  Scott A Reisman; David B Buckley; Yuji Tanaka; Curtis D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  2009-01-20       Impact factor: 4.219

4.  Nuclear factor-E2-related factor 2 expression in liver is critical for induction of NAD(P)H:quinone oxidoreductase 1 during cholestasis.

Authors:  Lauren M Aleksunes; Angela L Slitt; Jonathan M Maher; Matthew Z Dieter; Tamara R Knight; Michael Goedken; Nathan J Cherrington; Jefferson Y Chan; Curtis D Klaassen; José E Manautou
Journal:  Cell Stress Chaperones       Date:  2006       Impact factor: 3.667

5.  In vivo MRSI of hyperpolarized [1-(13)C]pyruvate metabolism in rat hepatocellular carcinoma.

Authors:  Moses M Darpolor; Yi-Fen Yen; Mei-Sze Chua; Lei Xing; Regina H Clarke-Katzenberg; Wenfang Shi; Dirk Mayer; Sonal Josan; Ralph E Hurd; Adolf Pfefferbaum; Lasitha Senadheera; Samuel So; Lawrence V Hofmann; Gary M Glazer; Daniel M Spielman
Journal:  NMR Biomed       Date:  2010-12-12       Impact factor: 4.044

6.  Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQO1-expressing cholangiocarcinoma cells.

Authors:  Benjaporn Buranrat; Auemduan Prawan; Upa Kukongviriyapan; Sarinya Kongpetch; Veerapol Kukongviriyapan
Journal:  World J Gastroenterol       Date:  2010-05-21       Impact factor: 5.742

7.  Editor's Highlight: Neonatal Activation of the Xenobiotic-Sensors PXR and CAR Results in Acute and Persistent Down-regulation of PPARα-Signaling in Mouse Liver.

Authors:  Cindy Yanfei Li; Sunny Lihua Cheng; Theo K Bammler; Julia Yue Cui
Journal:  Toxicol Sci       Date:  2016-07-13       Impact factor: 4.849

8.  Human liver-kidney model elucidates the mechanisms of aristolochic acid nephrotoxicity.

Authors:  Shih-Yu Chang; Elijah J Weber; Viktoriya S Sidorenko; Alenka Chapron; Catherine K Yeung; Chunying Gao; Qingcheng Mao; Danny Shen; Joanne Wang; Thomas A Rosenquist; Kathleen G Dickman; Thomas Neumann; Arthur P Grollman; Edward J Kelly; Jonathan Himmelfarb; David L Eaton
Journal:  JCI Insight       Date:  2017-11-16

9.  Safety assessment of the dietary supplement OxyELITE™ Pro (New Formula) in inbred and outbred mouse strains.

Authors:  Isabelle R Miousse; Charles M Skinner; Haixia Lin; Laura E Ewing; Stanley D Kosanke; D Keith Williams; Bharathi Avula; Ikhlas A Khan; Mahmoud A ElSohly; Bill J Gurley; Igor Koturbash
Journal:  Food Chem Toxicol       Date:  2017-08-24       Impact factor: 6.023

10.  Age-Specific Regulation of Drug-Processing Genes in Mouse Liver by Ligands of Xenobiotic-Sensing Transcription Factors.

Authors:  Cindy Yanfei Li; Helen J Renaud; Curtis D Klaassen; Julia Yue Cui
Journal:  Drug Metab Dispos       Date:  2015-11-17       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.